DE69816832D1 - Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen - Google Patents

Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen

Info

Publication number
DE69816832D1
DE69816832D1 DE69816832T DE69816832T DE69816832D1 DE 69816832 D1 DE69816832 D1 DE 69816832D1 DE 69816832 T DE69816832 T DE 69816832T DE 69816832 T DE69816832 T DE 69816832T DE 69816832 D1 DE69816832 D1 DE 69816832D1
Authority
DE
Germany
Prior art keywords
treatment
bridge
hydrogen
sleep disorders
benzazepines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69816832T
Other languages
English (en)
Other versions
DE69816832T2 (de
Inventor
Anders Fink-Jensen
Christian Foged
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Addex Pharmaceuticals SA
Original Assignee
Addex Pharmaceuticals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Addex Pharmaceuticals SA filed Critical Addex Pharmaceuticals SA
Publication of DE69816832D1 publication Critical patent/DE69816832D1/de
Application granted granted Critical
Publication of DE69816832T2 publication Critical patent/DE69816832T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69816832T 1997-03-12 1998-03-11 Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen Expired - Lifetime DE69816832T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK26597 1997-03-12
DK26597 1997-03-12
US4150997P 1997-03-24 1997-03-24
US41509P 1997-03-24
PCT/DK1998/000088 WO1998040072A1 (en) 1997-03-12 1998-03-11 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders

Publications (2)

Publication Number Publication Date
DE69816832D1 true DE69816832D1 (de) 2003-09-04
DE69816832T2 DE69816832T2 (de) 2004-05-27

Family

ID=26063641

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816832T Expired - Lifetime DE69816832T2 (de) 1997-03-12 1998-03-11 Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen

Country Status (16)

Country Link
US (1) US6211173B1 (de)
EP (1) EP1011679B1 (de)
JP (1) JP2001515484A (de)
AT (1) ATE245986T1 (de)
AU (1) AU742873B2 (de)
BR (1) BR9808234A (de)
CA (1) CA2283083C (de)
CZ (1) CZ296464B6 (de)
DE (1) DE69816832T2 (de)
DK (1) DK1011679T3 (de)
ES (1) ES2203933T3 (de)
IL (1) IL131670A (de)
NO (1) NO324719B1 (de)
PL (1) PL189822B1 (de)
PT (1) PT1011679E (de)
WO (1) WO1998040072A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006526021A (ja) * 2003-05-22 2006-11-16 シェーリング　コーポレイション 肥満およびｃｎｓ障害を治療する選択的ｄ１／ｄ５レセプタアンタゴニストとしての５ｈ−ベンゾ［ｄ］ナフト［２，１−ｂ］アゼピン誘導体
EP1691811B1 (de) * 2003-12-11 2014-07-23 Sunovion Pharmaceuticals Inc. Kombination aus einem sedativum und einem neurotransmitter-modulator und verfahren zur verbesserung der schlafqualität und zur behandlung von depression
US20050215521A1 (en) * 2003-12-22 2005-09-29 Karim Lalji Modafinil combination therapy for improving sleep quality
US20050164987A1 (en) * 2003-12-24 2005-07-28 Barberich Timothy J. Melatonin combination therapy for improving sleep quality
DK1742624T3 (da) * 2004-02-18 2010-03-08 Sepracor Inc Dopamin-agonist-kombinationsterapi med sedativer til forbedring af søvnkvalitet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK325188D0 (da) 1988-06-15 1988-06-15 Novo Industri As Hidtil ukendte benzazepinderivater
US5470850A (en) 1992-02-24 1995-11-28 Novo Nordisk A/S 2,3,4,5-tetrahydro-1H-3-benzazepines
DK26793D0 (da) 1993-03-10 1993-03-10 Novo Nordisk As Benzofuranyl- eller dihydrobenzofuranyl-substituerede tricycliske benzazepiner, der anvendelse og fremstilling

Also Published As

Publication number Publication date
DK1011679T3 (da) 2003-11-24
NO994343L (no) 1999-11-11
ATE245986T1 (de) 2003-08-15
JP2001515484A (ja) 2001-09-18
BR9808234A (pt) 2000-05-16
PT1011679E (pt) 2003-12-31
AU742873B2 (en) 2002-01-17
DE69816832T2 (de) 2004-05-27
CZ296464B6 (cs) 2006-03-15
EP1011679A1 (de) 2000-06-28
EP1011679B1 (de) 2003-07-30
ES2203933T3 (es) 2004-04-16
WO1998040072A1 (en) 1998-09-17
IL131670A0 (en) 2001-01-28
PL335545A1 (en) 2000-04-25
AU6610098A (en) 1998-09-29
US6211173B1 (en) 2001-04-03
CA2283083A1 (en) 1998-09-17
IL131670A (en) 2005-07-25
NO994343D0 (no) 1999-09-07
PL189822B1 (pl) 2005-09-30
CZ317799A3 (cs) 2000-03-15
NO324719B1 (no) 2007-12-03
CA2283083C (en) 2007-09-04

Similar Documents

Publication Publication Date Title
DE69503803D1 (de) 3,5-dioxo-(2h,4h)-1,2,4-triazinderivate ihre herstellung und verwendung als medikament
MY102866A (en) Amide derivatives.
FR2712591B1 (fr) Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
JO2321B1 (en) 4-phenyl-pyridine derivatives
ATE218860T1 (de) Verwendung von 3,4-diphenylchromanen zur herstellung eines arzneimittels zur behandlung bzw. vorbeugung des prostatakarzinoms
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ID26622A (id) Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide
HUP0204354A2 (hu) Új heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0001165A2 (hu) NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra
MY113427A (en) Anti-neurodegeneratively active 10-aminoaliphatyl- dibenz [b,f] oxepines
DE69816832D1 (de) Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen
ATE223379T1 (de) N-aryloxyethylaminderivate zur behandlung der depression
DK0847384T3 (da) Carbamoylcarboxylsyreamider
ATE158301T1 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
DE69911373D1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
TR199801683A2 (xx) Yeni �re t�revleri.
NO994104D0 (no) 5-hydroksymetyl-2-aminotetraliner i form av kardiovaskulaere midler
SE9603284D0 (sv) New compounds
ATE223406T1 (de) 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression
MX9705378A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de la obesidad.
MX9705218A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de ginecomastia idiopatica o fisiologica.
FI882421A (fi) 5-fenyl-1,2,3a,4,5,9b-hexahydro-3h -benz(e)indol, deras framstaellning och anvaendning som laekemedel.
MX9705379A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.
HUP0000679A2 (hu) 2,3,4,5-Tetrahidro-1H-benzazepinek alkalmazása alvási rendellenesség ellen ható gyógyászati készítmény előállítására
MX9705390A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ADDEX PHARMA SA, PLAN-LES-OUATES, GENEVE, CH